Long-Term Survival After Salvage Thoracic Surgery on a Patient with ALK-Rearranged Metastatic Lung Adenocarcinoma After Progression on Targeted Therapy

Targeted therapy for patients with advanced non-small cell lung cancer (NSCLC) is often challenged by the arising of drug resistance. After progression to targeted therapy, treatment options include continued targeted therapy, definitive local therapy, and the combination of both. While there is evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Kangqi, Ding, Guanggui, Xie, Shuying, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572106/
https://www.ncbi.nlm.nih.gov/pubmed/34754197
http://dx.doi.org/10.2147/OTT.S325460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572106/
https://www.ncbi.nlm.nih.gov/pubmed/34754197
http://dx.doi.org/10.2147/OTT.S325460

Ejemplares similares